What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q2 2019?

99 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q2 2019. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 61,553,639
Share change: +463,415
Total reported value: $236,256,732
Put/Call ratio: 174%
Price per share: $3.84
Number of holders: 99
Value change: -$4,762,099
Number of buys: 66
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 14888U101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Consonance Capital Management LP	13F	Company	15%	17,875,655	$91,166,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	5.7%	6,988,724	$35,643,000	—	31 Mar 2019	13F
Broadfin Capital, LLC	13F	Company	4.8%	5,856,998	$29,871,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	3.9%	4,765,795	$24,305,000	—	31 Mar 2019	13F
MANGROVE PARTNERS IM, LLC	13F	Company	2.8%	3,457,041	$17,631,000	—	31 Mar 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	2.4%	2,900,000	$14,790,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	1.9%	2,311,790	$11,791,000	—	31 Mar 2019	13F
Opaleye Management Inc.	13F	Company	1.5%	1,825,000	$9,308,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	1.3%	1,627,095	$8,298,000	—	31 Mar 2019	13F
ARMISTICE CAPITAL, LLC	13F	Company	1.2%	1,520,000	$7,752,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.93%	1,146,422	$5,846,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.92%	1,127,344	$5,749,000	—	31 Mar 2019	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.81%	999,787	$5,099,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.76%	938,476	$4,786,000	—	31 Mar 2019	13F
HAWK RIDGE CAPITAL MANAGEMENT LP	13F	Company	0.53%	654,859	$3,340,000	—	31 Mar 2019	13F
David M. Knott	13F	Individual	0.41%	510,847	$2,605,000	—	31 Mar 2019	13F
Informed Momentum Co LLC	13F	Company	0.4%	498,844	$2,544,000	—	31 Mar 2019	13F
GABLES CAPITAL MANAGEMENT INC.	13F	Company	0.39%	479,764	$2,449,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.37%	459,751	$2,344,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.33%	407,230	$2,077,000	—	31 Mar 2019	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.24%	297,238	$1,516,000	—	31 Mar 2019	13F
Global IMC LLC	13F	Company	0.22%	276,228	$1,409,000	—	31 Mar 2019	13F
ALPS ADVISORS INC	13F	Company	0.2%	248,154	$1,266,000	—	31 Mar 2019	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.19%	236,901	$1,208,000	—	31 Mar 2019	13F
TANAKA CAPITAL MANAGEMENT INC	13F	Company	0.19%	233,794	$1,192,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	226,188	$1,154,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.18%	218,143	$1,113,000	—	31 Mar 2019	13F
Brandywine Global Investment Management, LLC	13F	Company	0.17%	213,475	$1,089,000	—	31 Mar 2019	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.16%	197,594	$1,008,000	—	31 Mar 2019	13F
STRS OHIO	13F	Company	0.15%	190,600	$972,000	—	31 Mar 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.15%	186,708	$952,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	174,921	$892,000	—	31 Mar 2019	13F
ROYAL BANK OF CANADA	13F	Company	0.13%	165,000	$842,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.12%	148,765	$759,000	—	31 Mar 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.1%	128,300	$654,000	—	31 Mar 2019	13F
Lido Advisors, LLC	13F	Company	0.1%	126,403	$644,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.1%	124,197	$631,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	123,245	$629,000	—	31 Mar 2019	13F
Virtu Financial LLC	13F	Company	0.09%	112,568	$574,000	—	31 Mar 2019	13F
SEI INVESTMENTS CO	13F	Company	0.09%	112,169	$572,000	—	31 Mar 2019	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.08%	98,744	$503,000	—	31 Mar 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.07%	89,100	$454,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	87,489	$447,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.06%	76,194	$389,000	—	31 Mar 2019	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.05%	67,107	$342,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.05%	66,160	$338,000	—	31 Mar 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.05%	62,597	$319,000	—	31 Mar 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.05%	61,509	$314,000	—	31 Mar 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.04%	54,900	$280,000	—	31 Mar 2019	13F
MetLife Investment Management, LLC	13F	Company	0.04%	49,243	$251,139	—	31 Mar 2019	13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2019

As of 30 Jun 2019, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,553,639 shares. The largest 10 holders included Consonance Capital Management LP, BlackRock Inc., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MANGROVE PARTNERS, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, MORGAN STANLEY, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 99 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.